Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Pipeline Review, H2 2016; New Report Launched

Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) pipeline Target constitutes close to 11 molecules. Out of which approximately 9 molecules are developed by Companies and remaining by the Universities/Institutes. Global Markets Direct's latest report Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) – Pipeline Review, H2 2016, outlays comprehensive information on the Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) Neuronal acetylcholine receptor subunit beta-2 is a protein encoded by the CHRNB2 gene. Acetylcholine binds to this receptor. This results in extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane permeable to sodium ions. The molecules developed by Companies in Phase II, Preclinical and Discovery stages are 1, 4 and 4 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively.

Furthermore, this report also reviews key players involved in Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) targeted therapeutics development, features dormant and discontinued projects and latest news and press releases. Driven by data built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

For more information Visit at: http://mrr.cm/3SB

Related Reports;

CJ HealthCare Corp. - Product Pipeline Review - 2016 - Visit at - http://mrr.cm/3S2

Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016 - Visit at - http://mrr.cm/3S6

Eisai Co., Ltd. - Product Pipeline Review - 2016 - Visit at - http://mrr.cm/3Su

Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016 - Visit at - http://mrr.cm/3SL